Previous Close | 10.56 |
1-Year Change | -63.13% |
6-Months Change | -47.09% |
3-Months Change | -38.57% |
Moving Avg (50d) | 12.11 |
Moving Avg (200d) | 18.266 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 0.952B |
Beta (3-Years) | 1.85 |
Revenue Growth (ttm) | % |
Net Profit Margin (ttm) | % |
Return On Assets (ttm) | -42.2% |
EPS (ttm) | -3.19 |
PE Ratio (ttm) | -3.31 |
Dividend Yield | % |
Asset Description: | Rocket Pharmaceuticals, Inc. |
Predicted Direction: | Sell |
Signal Strength: | Sell |
Forecast Date: | 2025-01-29 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
10.771 | 11.088 | 11.299 | 11.616 | 12.144 | 12.672 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.